Seikagaku News

Seikagaku: Announcements of individual stocks related to personnel changes.

Aug 5 02:30 ET

Seikagaku: Announcements of individual stocks regarding the scheduled submission date of securities reports.

Jun 21 04:00 ET

Seikagaku: Announcements of individual stocks related to personnel changes.

Jun 14 02:00 ET

Seikagaku: Independent Officer Notification Form

May 22 04:00 ET

Seikagaku: Notice regarding acceptance of the SI-6603 approval application by the US FDA

May 13 22:30 ET

Seikagaku: Notice regarding changes in officers

Apr 23 02:00 ET

Seikagaku: Announcement of an academic conference presentation on SI-6603 by Ferring Pharmaceuticals

Apr 8 21:00 ET

Biochemical Industry: Notice regarding organizational changes and personnel changes

Mar 28 02:00 ET

Seikagaku: Notice regarding the postponement of the announcement of financial results for the 3rd quarter of the fiscal year ending March 31, 2024

Feb 8 01:00 ET

Seikagaku: Notice of support for the Reiwa 6 Noto Peninsula Earthquake

Jan 12 01:00 ET

Seikagaku: Notice regarding personnel changes

Sep 22, 2023 02:00 ET

Seikagaku: Notice Concerning Pivotal Test Results for Anti-Adhesion Material SI-449

Jul 20, 2023 21:00 ET

Seikagaku: Notice regarding personnel changes

Jun 14, 2023 02:00 ET

Seikagaku: Notice regarding top-line results of the phase III clinical trial (additional trial) of the lumbar disc herniation remedy SI-6603 in the United States

May 25, 2023 21:00 ET

Seikagaku: Independent Officer Notification Form

May 21, 2023 21:00 ET

Seikagaku: Notice regarding changes in officers, etc.

May 12, 2023 03:00 ET

Seikagaku: Notice regarding partial revisions to the Basic Internal Control Policy

Mar 30, 2023 03:00 ET

Seikagaku: Articles of association 2023-03-02

Mar 2, 2023 01:38 ET

Seikagaku: Notice on organizational change and personnel change

Dec 22, 2022 01:00 ET

Seikagaku: Notice on the formulation of a new medium-term business plan (March 2023 to March 2026)

Nov 16, 2022 21:00 ET